Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2019-01-11
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of exemestane in combination with
pemetrexed disodium and carboplatin in treating post-menopausal women with stage IV non-small
cell lung cancer. Exemestane may stop the growth of tumor calls by blocking some of the
enzymes need for cell growth. Drugs used in chemotherapy, such as pemetrexed disodium and
carboplatin, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. Giving exemestane together with pemetrexed disodium
and carboplatin may kill more tumor cells